View eBook

Sponsored by:
Carterra

eBooksResourcesAntibodies (Immune system)Antibody affinityAntibody specificityBioinformaticsBioinformatics softwareComputational biologyDiagnosisDiagnostic techniquesDrug development (Research and development)Drug research and developmentEarly-stage clinical drug developmentHigh throughput screeningImmune componentImmunologyMass spectrometryMedicine, Diagnosis, and TherapeuticsMonoclonal antibodiesPharmacologyResearch and developmentTechnology and Computational BiologyTherapeuticsCarterra
Previous articleDog Germs Diversify, May Threaten Humans with Flu Pandemics
Next articleHuman Glutamine Transporter Study May Generate Leads for Drug Development
Also of Interest
Related Media
AI Takes On Drug Discovery
Experimental Cancer Drug Slows Inflammation in Animal Models of Heart Disease
Protein-Protein Binding Forces Assessed at Single Molecule Level Using Sound Waves and DNA Leashes
Force of Nature: Caribou Biosciences Hits Clinical Runway with CRISPR-based Cancer Therapeutics
CDMOs RoslinCT and Lykan Team Up To Advance Cell and Gene Therapies
Rare Leukemia in the Skin Linked to Ultraviolet Radiation
Carl Icahn States His Case for Change at Illumina on “Close to the Edge”
Celebrating DNA: Matthew Cobb’s Reflections on the Double Helix
Emerging Markets Collaborate to Succeed in Post-Pandemic World
Book Review: The Exceptions
Search and Replace: Andrew Anzalone Details How Genome Editing Went Prime Time on “Close to the Edge”
The Sun Sets on AGBT: A Report from the Last Day